B-lynch Transverse Compression Suture

Launched by ALEXANDRIA UNIVERSITY · Apr 6, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a procedure called the B-Lynch transverse compression suture, which aims to help control excessive blood loss during surgery for women with a condition known as placenta previa. This condition occurs when the placenta covers the cervix, which can lead to complications during delivery. The trial is currently recruiting participants who are women aged between 18 and 45, who are pregnant with a single baby, and are scheduled for a planned cesarean section due to this condition.

To be eligible for the trial, women must have had at least two previous pregnancies and be diagnosed with placenta previa through an ultrasound. However, those with certain complications, such as a very firmly attached placenta or serious health issues like heart or liver problems, cannot participate. If you join the trial, you will undergo the B-Lynch suture procedure and be monitored to see how well it helps manage blood loss during your surgery. This study is important because it could lead to safer surgical options for women facing complications with their pregnancies.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Single gestation
• • 2. Elective CS for placenta preiva (diagnosed by transvaginal ultrasound).
• • 3. Muliparity (para 2 or more).
• Exclusion Criteria:
• • 1. Morbidly adherent placenta: accrete, increta or percreta, diagnosed by abdominal and/or transvaginal ultrasound.
• • Ultrasonographic features of morbidly adherent placentas:
• • Loss of Retro-placental sonolucent zone.
• • Vascular lacunae.
• • Myometrial thinning.
• • Interruption of the bladder border.
• • 2. More than 3 previous C.S.
• • 3. Severely haemodynamic instablility needing immediate hysterectomy.
• • 4. Patients with the cardiac, hepatic, renal or thromboembolic disease
• 5. Patients with coagulopathy:
• • Receiving anticoagulant therapy.
• • With thrombocytopenia or thrombasthenia.
• • Known coagulation factor defect.
• • 6. Distorted uterus as unicornuate, bicornuate, fibroid uterus and adenomyosis uteri.